Serum antithrombin III as an early predictive marker for post-hepatectomy liver failure: a prospective cohort study
Hye-Sung Jo, Sehyeon Yu, Su-Min Jeon, Yoo-Jin Choi, Young-Dong Yu, Dong-Sik Kim · 2026
Read Serum antithrombin III as an early predictive marker for post-hepatectomy liver failure: a prospective cohort study by Hye-Sung Jo, Sehyeon Yu, Su-Min Jeon, Yoo-Jin Choi, Young-Dong Yu, Dong-Sik Kim (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13402788.txt.
Description
Hye-Sung Jo and co-authors test a blood marker that may warn of liver failure after liver surgery, in a 2026 study. Failure of the remaining liver is a grave risk after major removal of liver tissue. Early warning is still an unmet need. The marker is a protein that helps control clotting.
The study enrolled 151 patients at high risk for the failure. Blood levels of the marker were checked before surgery and on four days after. Failure struck 35 patients, about 23 percent. Their marker levels were lower at every check. A drop of 30 percent or more by day three more than tripled the odds of failure. Such a test could flag patients for closer care.
Catalog record
| CREATOR | Hye-Sung Jo, Sehyeon Yu, Su-Min Jeon, Yoo-Jin Choi, Young-Dong Yu, Dong-Sik Kim |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |